[HTML][HTML] Cervical cancer in low and middle‑income countries

R Hull, M Mbele, T Makhafola, C Hicks… - Oncology …, 2020 - spandidos-publications.com
Cervical cancer is a malignant tumour that occurs in the cervix and is classified into two
histological types, adenocarcinoma and squamous cell carcinoma (SCC); SCC is more …

Epidemiology of human papillomavirus–positive head and neck squamous cell carcinoma

ML Gillison, AK Chaturvedi, WF Anderson… - Journal of clinical …, 2015 - ascopubs.org
Human papillomavirus (HPV) is now established as the principal cause of an increase in
incidence of a subset of head and neck squamous cell cancers (HNCs) in numerous …

Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income …

M Brisson, JJ Kim, K Canfell, M Drolet, G Gingras… - The Lancet, 2020 - thelancet.com
Summary Background The WHO Director-General has issued a call for action to eliminate
cervical cancer as a public health problem. To help inform global efforts, we modelled …

Worldwide burden of cancer attributable to HPV by site, country and HPV type

C De Martel, M Plummer, J Vignat… - International journal of …, 2017 - Wiley Online Library
HPV is the cause of almost all cervical cancer and is responsible for a substantial fraction of
other anogenital cancers and oropharyngeal cancers. Understanding the HPV‐attributable …

Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020–99: a …

KT Simms, J Steinberg, M Caruana, MA Smith… - The lancet …, 2019 - thelancet.com
Background Cervical screening and human papillomavirus (HPV) vaccination have been
implemented in most high-income countries; however, coverage is low in low-income and …

Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis

L Bruni, M Diaz, L Barrionuevo-Rosas… - The Lancet global …, 2016 - thelancet.com
Background Since 2006, many countries have implemented publicly funded human
papillomavirus (HPV) immunisation programmes. However, global estimates of the extent …

[HTML][HTML] Human papillomavirus-related oropharyngeal cancer

M Taberna, M Mena, MA Pavón, L Alemany… - Annals of …, 2017 - Elsevier
High-risk human papillomavirus (HPV) is now recognised as the principal cause of the
increasing incidence rates of oropharyngeal squamous cell carcinoma (OPSCC) in some …

Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis

M Drolet, É Bénard, MC Boily, H Ali… - The Lancet infectious …, 2015 - thelancet.com
Background Human papillomavirus (HPV) vaccination programmes were first implemented
in several countries worldwide in 2007. We did a systematic review and meta-analysis to …

Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world

J Toor, S Echeverria-Londono, X Li, K Abbas… - Elife, 2021 - elifesciences.org
Background: Vaccination is one of the most effective public health interventions. We
investigate the impact of vaccination activities for Haemophilus influenzae type b, hepatitis …

Building the foundations for sustainable development: a case for global investment in the capabilities of adolescents

P Sheehan, K Sweeny, B Rasmussen, A Wils… - The Lancet, 2017 - thelancet.com
Investment in the capabilities of the world's 1· 2 billion adolescents is vital to the UN's
Sustainable Development Agenda. We examined investments in countries of low income …